Ovarian Cancer at Johns Hopkins What's New? Resources Ovarian Cancer Community Coping with Ovarian Cancer Clinical Trials
 

You Should Know

Anatomy

Prevention

Risk Factors

Genetics

Screening

CA 125

Symptoms

Early Detection

Diagnosis

Radiology

Pathologists

Staging

Treatment

Recurrent Disease

Recurrent Q & A

Nutrition

Prognosis

Clinical Trials

Glossary

Discussion Board

Questions for Dr.


Diagnosis: Types of Tumors

Atypical proliferative ("borderline") serous tumors

Back
The disease-specific survival rate of patients with APSTs confined to the ovaries, or with "microinvasion" or even with "lymph node involvement" approaches 100%. The behavior of APSTs with extraovarian disease is based on the type of implants that are present. The survival rate of patients with APSTs with noninvasive implants is 95-100% after a mean follow-up of 7.4 years. In general, the noninvasive serous tumors associated with invasive implants are micropapillary serous carcinomas, not APSTs.

  
     
HONcode Logo We subscribe to the HONcode principles. Verify

Copyright © 2000-2009 Johns Hopkins University.
All rights reserved.
Disclaimer & Privacy    Last modified April 23, 2001